Literature DB >> 9651882

Mapping of dopamine D3 receptor binding site by pharmacological characterization of mutants expressed in CHO cells with the Semliki Forest virus system.

K Lundstrom1, M P Turpin, C Large, G Robertson, P Thomas, X Q Lewell.   

Abstract

Nine mutants and the wild-type human dopamine D3 receptor were expressed at high levels in BHK and CHO cells using the Semliki Forest virus system and were analysed for receptor binding with several structurally different dopamine D3 ligands. The mutation His349Leu showed a significant decrease in pKi values for raclopride, dopamine and GR218231, but an increase in affinity for GR99841. Thr369Val had an increase in pKi for both GR99841 and 7-OH-DPAT. The receptor modelling based on sequence alignment with bacteriorhodopsin indicated that Thr369 and His349 are located on the inside of the ligand binding pocket and the effect of the mutagenesis was therefore expected. The change in binding affinity for Thr369Val could be due to the location in the transmembrane domain VII close to the aspartate residue in domain III, the postulated counter ion for dopamine.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9651882     DOI: 10.3109/10799899809047741

Source DB:  PubMed          Journal:  J Recept Signal Transduct Res        ISSN: 1079-9893            Impact factor:   2.092


  11 in total

1.  Structurally constrained hybrid derivatives containing octahydrobenzo[g or f]quinoline moieties for dopamine D2 and D3 receptors: binding characterization at D2/D3 receptors and elucidation of a pharmacophore model.

Authors:  Dennis A Brown; Prashant S Kharkar; Ingrid Parrington; Maarten E A Reith; Aloke K Dutta
Journal:  J Med Chem       Date:  2008-12-25       Impact factor: 7.446

2.  A structural chemogenomics analysis of aminergic GPCRs: lessons for histamine receptor ligand design.

Authors:  A J Kooistra; S Kuhne; I J P de Esch; R Leurs; C de Graaf
Journal:  Br J Pharmacol       Date:  2013-09       Impact factor: 8.739

3.  Homology Model Versus X-ray Structure in Receptor-based Drug Design: A Retrospective Analysis with the Dopamine D3 Receptor.

Authors:  Nicolas Levoin; Thierry Calmels; Stéphane Krief; Denis Danvy; Isabelle Berrebi-Bertrand; Jeanne-Marie Lecomte; Jean-Charles Schwartz; Marc Capet
Journal:  ACS Med Chem Lett       Date:  2011-02-11       Impact factor: 4.345

Review 4.  The potential role of dopamine D₃ receptor neurotransmission in cognition.

Authors:  Shinichiro Nakajima; Philip Gerretsen; Hiroyoshi Takeuchi; Fernando Caravaggio; Tiffany Chow; Bernard Le Foll; Benoit Mulsant; Bruce Pollock; Ariel Graff-Guerrero
Journal:  Eur Neuropsychopharmacol       Date:  2013-06-20       Impact factor: 4.600

5.  Interaction of novel hybrid compounds with the D3 dopamine receptor: Site-directed mutagenesis and homology modeling studies.

Authors:  Sandhya Kortagere; Shu-Yuan Cheng; Tamara Antonio; Juan Zhen; Maarten E A Reith; Aloke K Dutta
Journal:  Biochem Pharmacol       Date:  2010-09-15       Impact factor: 5.858

Review 6.  Genetics and the placebo effect: the placebome.

Authors:  Kathryn T Hall; Joseph Loscalzo; Ted J Kaptchuk
Journal:  Trends Mol Med       Date:  2015-04-14       Impact factor: 11.951

7.  Concentration of receptor and ligand revisited in a modified receptor binding protocol for high-affinity radioligands: [3H]Spiperone binding to D2 and D3 dopamine receptors.

Authors:  Juan Zhen; Tamara Antonio; Aloke K Dutta; Maarten E A Reith
Journal:  J Neurosci Methods       Date:  2010-02-01       Impact factor: 2.390

8.  Dopamine D1 receptor agonist and D2 receptor antagonist effects of the natural product (-)-stepholidine: molecular modeling and dynamics simulations.

Authors:  Wei Fu; Jianhua Shen; Xiaomin Luo; Weiliang Zhu; Jiagao Cheng; Kunqian Yu; James M Briggs; Guozhang Jin; Kaixian Chen; Hualiang Jiang
Journal:  Biophys J       Date:  2007-04-27       Impact factor: 4.033

9.  Potential modes of interaction of 9-aminomethyl-9,10-dihydroanthracene (AMDA) derivatives with the 5-HT2A receptor: a ligand structure-affinity relationship, receptor mutagenesis and receptor modeling investigation.

Authors:  Scott P Runyon; Philip D Mosier; Bryan L Roth; Richard A Glennon; Richard B Westkaemper
Journal:  J Med Chem       Date:  2008-10-11       Impact factor: 7.446

10.  Ring substituents on substituted benzamide ligands indirectly mediate interactions with position 7.39 of transmembrane helix 7 of the D4 dopamine receptor.

Authors:  Spencer S Ericksen; David F Cummings; Michael E Teer; Shahnawaz Amdani; John A Schetz
Journal:  J Pharmacol Exp Ther       Date:  2012-05-15       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.